ORKA
Oruka Therapeutics, Inc.
NasdaqGMUSDEQUITY
DELAYED
Last price
106.82
▲ 1.96 (1.87%)
MARKET · —
Price
Open
101.56
Prev close
104.86
Day high
109.52
Day low
103.86
Volume
839.82K
Market cap
—
P/E (TTM)
—
52W range
14.34 – 115.52
Trailing performance
Returnvs SPY
1W
-2.77%
-1.4%
1M
+17.41%
+13.7%
3M
+83.95%
+80.9%
6M
+233.83%
+222.8%
YTD
+256.19%
+243.9%
1Y
+649.72%
+629.7%
3Y
+343.19%
+269.0%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
108.46
-1.51% from price
SMA 20
101.75
+6.10% from price
SMA 50
91.43
+18.08% from price
SMA 100
77.18
+38.41% from price
SMA 200
54.82
+96.92% from price
EMA 12
106.14
+0.64% from price
EMA 26
100.40
+6.39% from price
EMA 50
91.99
+16.12% from price
RSI (14)
62.1
Neutral
MACD (12,26,9)
5.74
Hist -0.11
ATR (14)
5.31
4.92% of price
Realised vol 30D
57.3%
Annualised
Bollinger upper
116.79
20, 2σ
Bollinger lower
86.72
20, 2σ
50 / 200 cross
Golden
91.43 vs 54.82
Trend bias
Above 200
+96.92%
Risk profile
Beta vs SPY
1.47
More volatile than market
Correlation to SPY
0.25
Largely independent
Realised vol 30D
57.3%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-28.0%
Peak to trough
Max drawdown 5Y
-86.4%
Peak to trough
ATR 14
5.31
4.92% of price
Beta (reported)
—
5Y monthly, from filing
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Headlines
Oruka Therapeutics Files $1 Billion Mixed Shelf
MT Newswires · 16h ago
Oruka Therapeutics Insider Sold Shares Worth $5,641,409, According to a Recent SEC Filing
MT Newswires · 8d ago
Oruka Therapeutics Insider Sold Shares Worth $1,066,572, According to a Recent SEC Filing
MT Newswires · 8d ago
4 Psoriasis Drug Stocks to Watch During Psoriasis Awareness Month 2026
Zacks · 11d ago
Oruka Therapeutics Q2 Loss Widens
MT Newswires · 12d ago
Oruka Therapeutics Insider Sold Shares Worth $846,180, According to a Recent SEC Filing
MT Newswires · 40d ago
HMI Capital Pares Its Stake in AI Company nCino
Barrons.com · 43d ago
Oruka Therapeutics Insider Sold Shares Worth $472,079, According to a Recent SEC Filing
MT Newswires · 51d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.